aurobindo pharma (GoldmanSachs) Inline with expectations: Margin decline more than forecast; Neutral

Date Rating Target Price Recommendation Price Broker house
11 May 2011 neutral 213 (From 226) 181 GoldmanSachs Report

No comments:

Post a Comment